| __timestamp | Catalyst Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 13774000 |
| Thursday, January 1, 2015 | 8597010 | 22479000 |
| Friday, January 1, 2016 | 7910260 | 27388000 |
| Sunday, January 1, 2017 | 7304399 | 35610000 |
| Monday, January 1, 2018 | 15875961 | 49007000 |
| Tuesday, January 1, 2019 | 36881187 | 61139000 |
| Wednesday, January 1, 2020 | 44233754 | 68836000 |
| Friday, January 1, 2021 | 49628000 | 97592000 |
| Saturday, January 1, 2022 | 58183000 | 106903000 |
| Sunday, January 1, 2023 | 133710000 | 120998000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Vericel Corporation and Catalyst Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, both companies have shown significant growth in their SG&A expenses, reflecting their strategic investments in marketing, administration, and sales.
Catalyst Pharmaceuticals, Inc. witnessed a staggering 2,890% increase in SG&A expenses, peaking in 2023. Meanwhile, Vericel Corporation's expenses surged by approximately 780%, reaching their highest in the same year. This trend underscores the competitive nature of the industry, where companies are investing heavily to capture market share and drive innovation. As these companies continue to expand, understanding their cost management strategies becomes essential for investors and stakeholders alike.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights